Delivery Order SPE2DB24D2205-SPE2DB24FDZTW
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$37K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,571,366 units of ondansetron HCL 8 mg tablets. The contract has a ceiling value of $36,395.26 and a completion date of March 14, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of Ondansetron HCL 8 mg tablets. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm-fixed price of $24,597.35 and a period of performance through October 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award is for the delivery of 4,565,470,676 units of Ondansetron HCL 8 mg tablets by Amerisourcebergen Drug Corp to the U.S. government. The contract, valued at $7,519.33, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the supply of Ondansetron HCL 4 mg tablets to support the healthcare needs of military treatment facilities and programs. The $6,465.30 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of...
This federal contract award is for the delivery of 4 mg ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award is for the supply of Ondansetron HCL 8 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,019.21, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,767.98, is for the delivery of Ondansetron HCL 4 mg tablets to support military and federal healthcare programs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 8 mg Ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA) under a Delivery Order worth $8,518.69. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop...
This federal contract award is for the delivery of 4,566,307,173 units of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,124.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $1,179.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of March 14, 2025, is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30s. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...